• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Cytospin-A (SPECC1L), Truncated

ACP16990

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP16990 Target NameSPECC1L
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Protein LengthPartialPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ69YQ0
Background Information
  • Uniprot Id

    Q69YQ0

  • Target Species

    Human

  • Target Name

    SPECC1L

  • Target Full Name

    Cytospin-A

  • Target Function

    Involved in cytokinesis and spindle organization. May play a role in actin cytoskeleton organization and microtubule stabilization and hence required for proper cell adhesion and migration.

  • Target Involvement

    Facial clefting, oblique, 1 (OBLFC1); Opitz GBBB syndrome 2 (GBBB2)

  • Target Subcellular Location

    Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, spindle. Cell junction, gap junction. Note=Colocalizes with acetylated alpha-tubulin, gamma-tubulin and F-actin. Also observed in a ring around gamma-tubulin containing centrioles possibly in the microtubule organizing center.

  • Target Protein Families

    Cytospin-A family

  • Target Synonyms

    Cytokinesis and spindle organization A; Cytospin-A; CYTSA; CYTSA_HUMAN; KIAA0376; OBLFC1; Renal carcinoma antigen NY-REN-22; SPECC1-like protein; specc1l; Sperm antigen with calponin homology and coiled-coil domains 1-like

Inquire Recombinant Human Cytospin-A (SPECC1L), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification